Predicting frequent COPD exacerbations using primary care data

International Journal of COPD

Volumn 10, Issue 1, 2015, Pages 2439-2450

  Kerkhof, Marjan ^a   Freeman, Daryl ^b   Jones, Rupert ^c   Chisholm, Alison ^d   Price, David B ^a,e  

^a Research in Real Life   (United Kingdom)

^b Mundesley Medical Centre Mundesley   (United Kingdom)

^c PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

^d Respiratory Effectiveness Group   (United Kingdom)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

FEV1; Model; Prediction; Risk factor; Validation

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASSESSMENT OF HUMANS; BODY HEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICALLY BASED MODEL; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; COPD ASSESSMENT TEST SCORE; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA AIRFLOW OBSTRUCTION SMOKING STATUS AND EXACERBATION FREQUENCY INDEX SCORE; EOSINOPHILIA; EXTERNAL VALIDITY; FACTUAL DATABASE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENERAL ASPECTS OF DISEASE; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; INFORMATION PROCESSING; INTERNAL VALIDITY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MODIFIED MEDICAL RESEARCH COUNCIL SCORE; NONBIOLOGICAL MODEL; NUMBER OF EXACERBATION; OPTIMUM PATIENT CARE RESEARCH DATABASE; PATIENT IDENTIFICATION; PREDICTIVE VALUE; PRIMARY CARE DATA; QUESTIONNAIRE; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY ANALYSIS; VALIDATION PROCESS; ADVERSE EFFECTS; DISEASE COURSE; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE; PROCEDURES; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECURRENT DISEASE; REPRODUCIBILITY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SMOKING; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UNITED KINGDOM;

AGED; COMORBIDITY; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; SYMPTOM FLARE UP; UNITED KINGDOM;

EID: 84947054202     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S94259     Document Type: Article

References (39)

1. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347-365.
2. Punekar YS, Shukla A, Mullerova H. COPD management costs according to the frequency of COPD exacerbations in UK primary care. Int J Chron Obstruct Pulmon Dis. 2014;9:65-73.
3. Croxton TL, Weinmann GG, Senior RM, Wise RA, Crapo JD, Buist AS. Clinical research in chronic obstructive pulmonary disease: needs and opportunities. Am J Respir Crit Care Med. 2003;167(8):1142-1149.
4. Celli B, Cross S, Grossman R, et al. Improving the care of COPD patients - suggested action points by the COPD exacerbations taskforce for reducing the burden of exacerbations of COPD. Prim Care Respir J. 2006;15(3):139-142.
5. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012;379(9823):1341-1351.
6. Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med. 2012;186(10):975-981.
7. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD, 2015; 2015. Available from: http://www.goldcopd.org/. Accessed July 7, 2015.
8. Han MK, Muellerova H, Curran-Everett D, et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med. 2013;1(1):43-50.
9. Motegi T, Jones RC, Ishii T, et al. A comparison of three multidimensional indices of COPD severity as predictors of future exacerbations. Int J Chron Obstruct Pulmon Dis. 2013;8:259-271.
10. Faganello MM, Tanni SE, Sanchez FF, Pelegrino NR, Lucheta PA, Godoy I. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease. Am J Med Sci. 2010;339(1):10-14.
11. Jones RC, Donaldson GC, Chavannes NH, et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. Am J Respir Crit Care Med. 2009;180(12):1189-1195.
12. Jones R, Price D, Chavannes N, et al. A comparison of multi-component indices of COPD severity in primary care: an UNLOCK study from the IPCRG. Eur Respir J. 2013;42(suppl 57):2006.
13. Garcia-Aymerich J, Monsó E, Marrades RM, et al; EFRAM Investigators. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Am J Respir Crit Care Med. 2001;164(6):1002-1007.
14. Foreman MG, DeMeo DL, Hersh CP, Reilly JJ, Silverman EK. Clinical determinants of exacerbations in severe, early-onset COPD. Eur Respir J. 2007;30(6):1124-1130.
15. Bahadori K, FitzGerald JM, Levy RD, Fera T, Swiston J. Risk factors and outcomes associated with chronic obstructive pulmonary disease exacerbations requiring hospitalization. Can Respir J. 2009;16(4):e43-e49.
16. Bertens LC, Reitsma JB, Moons KG, et al. Development and validation of a model to predict the risk of exacerbations in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2013;8:493-499.
17. Fan VS, Ramsey SD, Make BJ, Martinez FJ. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD. COPD. 2007;4(1):29-39.
18. Niewoehner DE, Lokhnygina Y, Rice K, et al. Risk indexes for exacerbations and hospitalizations due to COPD. Chest. 2007;131(1):20-28.
19. Austin PC, Stanbrook MB, Anderson GM, Newman A, Gershon AS. Comparative ability of comorbidity classification methods for administrative data to predict outcomes in patients with chronic obstructive pulmonary disease. Ann Epidemiol. 2012;22(12):881-887.
20. Rowe BH, Villa-Roel C, Guttman A, et al. Predictors of hospital admission for chronic obstructive pulmonary disease exacerbations in Canadian emergency departments. Acad Emerg Med. 2009;16(4):316-324.
21. Stiell IG, Clement CM, Aaron SD, et al. Clinical characteristics associated with adverse events in patients with exacerbation of chronic obstructive pulmonary disease: a prospective cohort study. CMAJ. 2014;186(6):E193-E204.
22. Liu D, Peng SH, Zhang J, Bai SH, Liu HX, Qu JM. Prediction of short term re-exacerbation in patients with acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:1265-1273.
23. Optimum Patient Care Research Database (OPCRD). Available from: http://optimumpatientcare.org/. Accessed July 7, 2015.
24. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581-586.
25. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648-654.
26. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: Wiley; 1989.
27. Hoogendoorn M, Feenstra TL, Hoogenveen RT, Al M, Molken MR. Association between lung function and exacerbation frequency in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2010;5:435-444.
28. Kruis AL, Ställberg B, Jones RC, et al. Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation study. PLoS One. 2014;9(3):e90145.
29. Jones RC, Price D, Ryan D, et al; Respiratory Effectiveness Group. Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. Lancet Respir Med. 2014;2(4):267-276.
30. Pencina MJ, D'Agostino RB Sr. Evaluating discrimination of risk prediction models: the C statistic. JAMA. 2015;314(10):1063-1064.
31. Miravitlles M, Guerrero T, Mayordomo C, Sanchez-Agudo L, Nicolau F, Segu JL. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group. Respiration. 2000;67(5):495-501.
32. Hurst JR, Vestbo J, Anzueto A, et al; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128-1138.
33. Bowler RP, Kim V, Regan E, et al; COPDGene Investigators. Prediction of acute respiratory disease in current and former smokers with and without COPD. Chest. 2014;146(4):941-950.
34. Müllerová H, Shukla A, Hawkins A, Quint J. Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study. BMJ Open. 2014;4(12):e006171.
35. Make BJ, Eriksson G, Calverley PM, et al. A score to predict short-term risk of COPD exacerbations (SCOPEX). Int J Chron Obstruct Pulmon Dis. 2015;10:201-209.
36. Saha S, Brightling CE. Eosinophilic airway inflammation in COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(1):39-47.
37. Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet. 2009;374(9691):704-711.
38. Hardin M, Silverman EK, Barr RG, et al; COPDGene Investigators. The clinical features of the overlap between COPD and asthma. Respir Res. 2011;12:127.
39. Papaiwannou A, Zarogoulidis P, Porpodis K, et al. Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review. J Thorac Dis. 2014;6(suppl 1):S146-S151.